$CAH
CARDINAL HEALTH INC

2024 Q1 Form 10-Q Financial Statement

#000162828024002813 Filed on February 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $54.91B $57.45B
YoY Change 8.76% 11.61%
Cost Of Revenue $52.96B $55.60B
YoY Change 8.75% 11.63%
Gross Profit $1.947B $1.846B
YoY Change 9.08% 11.0%
Gross Profit Margin 3.55% 3.21%
Selling, General & Admin $1.282B $1.283B
YoY Change 8.74% 7.72%
% of Gross Profit 65.84% 69.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $177.0M $175.0M
YoY Change 1.14% 2.94%
% of Gross Profit 9.09% 9.48%
Operating Expenses $1.282B $1.283B
YoY Change 8.74% 7.72%
Operating Profit $367.0M $482.0M
YoY Change -35.84% -505.04%
Interest Expense $33.00M $8.000M
YoY Change 17.86% -68.0%
% of Operating Profit 8.99% 1.66%
Other Income/Expense, Net $7.000M $16.00M
YoY Change 128.57%
Pretax Income $341.0M $490.0M
YoY Change -37.32% -457.66%
Income Tax $82.00M $136.0M
% Of Pretax Income 24.05% 27.76%
Net Earnings $258.0M $353.0M
YoY Change -25.22% -371.54%
Net Earnings / Revenue 0.47% 0.61%
Basic Earnings Per Share $1.07 $1.50
Diluted Earnings Per Share $1.05 $1.44
COMMON SHARES
Basic Shares Outstanding 243.2M shares 246.5M shares
Diluted Shares Outstanding 245.0M shares 246.0M shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.718B $4.591B
YoY Change -6.82% 25.64%
Cash & Equivalents $3.718B $4.591B
Short-Term Investments
Other Short-Term Assets $3.161B $2.816B
YoY Change 66.81% 24.71%
Inventory $17.28B $18.45B
Prepaid Expenses
Receivables $11.57B $11.79B
Other Receivables $0.00 $0.00
Total Short-Term Assets $35.73B $37.66B
YoY Change 6.68% 8.85%
LONG-TERM ASSETS
Property, Plant & Equipment $2.470B $2.446B
YoY Change 4.57% 4.49%
Goodwill $4.788B $4.024B
YoY Change -4.24% -19.29%
Intangibles $1.719B $1.347B
YoY Change 9.7% -17.46%
Long-Term Investments
YoY Change
Other Assets $1.169B $1.098B
YoY Change 22.92% 18.45%
Total Long-Term Assets $10.15B $8.915B
YoY Change 2.69% -9.82%
TOTAL ASSETS
Total Short-Term Assets $35.73B $37.66B
Total Long-Term Assets $10.15B $8.915B
Total Assets $45.88B $46.57B
YoY Change 5.77% 4.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.09B $34.26B
YoY Change 8.41% 13.88%
Accrued Expenses $3.030B $2.839B
YoY Change 5.35% 11.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.187B $1.188B
YoY Change 4465.38% 105.89%
Total Short-Term Liabilities $36.31B $38.29B
YoY Change 11.7% 15.28%
LONG-TERM LIABILITIES
Long-Term Debt $4.667B $3.535B
YoY Change -0.87% -24.55%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.667B $3.535B
YoY Change -0.87% -24.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.31B $38.29B
Total Long-Term Liabilities $4.667B $3.535B
Total Liabilities $49.15B $50.02B
YoY Change 7.78% 7.13%
SHAREHOLDERS EQUITY
Retained Earnings -$289.0M -$425.0M
YoY Change -15.5% -24.11%
Common Stock $2.887B $2.855B
YoY Change 2.45% 3.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.703B $5.724B
YoY Change 25.23% 34.56%
Treasury Stock Shares
Shareholders Equity -$3.265B -$3.449B
YoY Change
Total Liabilities & Shareholders Equity $45.88B $46.57B
YoY Change 5.77% 4.7%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $258.0M $353.0M
YoY Change -25.22% -371.54%
Depreciation, Depletion And Amortization $177.0M $175.0M
YoY Change 1.14% 2.94%
Cash From Operating Activities -$49.00M $1.189B
YoY Change -103.6% 99.16%
INVESTING ACTIVITIES
Capital Expenditures $112.0M $114.0M
YoY Change 2.75% -234.12%
Acquisitions
YoY Change
Other Investing Activities -$1.735B $9.000M
YoY Change -9738.89% -550.0%
Cash From Investing Activities -$1.847B -$105.0M
YoY Change 1929.67% 20.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.031B -353.0M
YoY Change -210.39% -2.49%
NET CHANGE
Cash From Operating Activities -49.00M 1.189B
Cash From Investing Activities -1.847B -105.0M
Cash From Financing Activities 1.031B -353.0M
Net Change In Cash -865.0M 731.0M
YoY Change -357.44% 393.92%
FREE CASH FLOW
Cash From Operating Activities -$49.00M $1.189B
Capital Expenditures $112.0M $114.0M
Free Cash Flow -$161.0M $1.075B
YoY Change -112.86% 57.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-130000000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-130000000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
30000000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List
DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#GainLossOnSalesOfAssetsAndAssetImpairmentCharges
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
254000000 usd
CY2023Q4 us-gaap Dividends
Dividends
123000000 usd
CY2023Q4 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3447000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1780000000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
47000000 usd
CY2022Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
250000000 usd
CY2022Q4 us-gaap Dividends
Dividends
129000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2212000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2851000000 usd
us-gaap Net Income Loss
NetIncomeLoss
358000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1000000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
57000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
759000000 usd
us-gaap Dividends
Dividends
249000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3447000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-706000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-20000000 usd
us-gaap Profit Loss
ProfitLoss
-19000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-32000000 usd
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
2000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
58000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1250000000 usd
us-gaap Dividends
Dividends
260000000 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2212000000 usd
us-gaap Profit Loss
ProfitLoss
360000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
347000000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-538000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
57000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
43000000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
487000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2536000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4446000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1034000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1734000000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9000000 usd
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
206000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
155000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000000 usd
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
2000000 usd
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
5000000 usd
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
1000000 usd
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
1000000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
28000000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-168000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-157000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13000000 usd
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
1000000 usd
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
9000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
255000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
271000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
750000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1250000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1019000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1525000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
548000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1063000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4043000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4717000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4591000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3654000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
174000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
148000000 usd
CY2023Q4 us-gaap Severance Costs1
SeveranceCosts1
8000000 usd
CY2022Q4 us-gaap Severance Costs1
SeveranceCosts1
10000000 usd
CY2023Q4 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
20000000 usd
CY2022Q4 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
7000000 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
28000000 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
17000000 usd
us-gaap Severance Costs1
SeveranceCosts1
15000000 usd
us-gaap Severance Costs1
SeveranceCosts1
29000000 usd
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
38000000 usd
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
17000000 usd
us-gaap Restructuring Charges
RestructuringCharges
53000000 usd
us-gaap Restructuring Charges
RestructuringCharges
46000000 usd
us-gaap Revenues
Revenues
101072000000 usd
CY2023Q4 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
14000000 usd
CY2022Q4 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
5000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
46000000 usd
us-gaap Restructuring Costs
RestructuringCosts
12000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
19000000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
39000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
4609000000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-3000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1000000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
581000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4024000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
12000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
12000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4743000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3408000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1335000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4755000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3408000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1347000000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
11000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4741000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3280000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1461000000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4752000000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3280000000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1472000000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
63000000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
127000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
142000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
127000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
226000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
206000000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4700000000 usd
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
4700000000 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
34300000000 usd
CY2023Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
29800000000 usd
CY2023Q4 cah Incomefrom Settlementsof Class Action Lawsuits
IncomefromSettlementsofClassActionLawsuits
31000000 usd
cah Incomefrom Settlementsof Class Action Lawsuits
IncomefromSettlementsofClassActionLawsuits
71000000 usd
cah Incomefrom Settlementsof Class Action Lawsuits
IncomefromSettlementsofClassActionLawsuits
66000000 usd
CY2022Q4 cah Incomefrom Settlementsof Class Action Lawsuits
IncomefromSettlementsofClassActionLawsuits
66000000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.277
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
959000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1000000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
864000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
873000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
52000000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
65000000 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2023Q4 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2022Q4 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 usd
CY2023Q4 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
4723000000 usd
CY2023Q2 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
4701000000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1000000 usd
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
5000000 usd
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
20000000 usd
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
11000000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
261000000 shares
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246000000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
261000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
247000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
266000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
248000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
266000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
cah Shares That Would Be Antidilutive As A Result Of Net Loss
SharesThatWouldBeAntidilutiveAsAResultOfNetLoss
2000000 shares
CY2022Q4 cah Shares That Would Be Antidilutive As A Result Of Net Loss
SharesThatWouldBeAntidilutiveAsAResultOfNetLoss
2000000 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q4 us-gaap Revenues
Revenues
57445000000 usd
CY2022Q4 us-gaap Revenues
Revenues
51469000000 usd
us-gaap Revenues
Revenues
112208000000 usd
us-gaap Revenues
Revenues
101072000000 usd
CY2023Q4 us-gaap Revenues
Revenues
57445000000 usd
CY2022Q4 us-gaap Revenues
Revenues
51469000000 usd
us-gaap Revenues
Revenues
112208000000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
482000000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-119000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
468000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
18000000 usd
CY2023Q4 us-gaap Assets
Assets
46573000000 usd
CY2023Q2 us-gaap Assets
Assets
43417000000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28000000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
57000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48000000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4000000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
8000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6000000 usd

Files In Submission

Name View Source Status
cah-20231231_lab.xml Edgar Link unprocessable
cah-20231231_cal.xml Edgar Link unprocessable
0001628280-24-002813-index-headers.html Edgar Link pending
0001628280-24-002813-index.html Edgar Link pending
0001628280-24-002813.txt Edgar Link pending
0001628280-24-002813-xbrl.zip Edgar Link pending
a24q2_10qx123123xexhibit101.htm Edgar Link pending
a24q2_10qx123123xexhibit311.htm Edgar Link pending
a24q2_10qx123123xexhibit312.htm Edgar Link pending
a24q2_10qx123123xexhibit321.htm Edgar Link pending
a24q2_10qx123123xexhibit991.htm Edgar Link pending
cah-20231231.htm Edgar Link pending
cah-20231231.xsd Edgar Link pending
cah-20231231_g1.jpg Edgar Link pending
cah-20231231_g2.jpg Edgar Link pending
cah-20231231_g3.jpg Edgar Link pending
cah-20231231_g4.jpg Edgar Link pending
cah-20231231_g5.jpg Edgar Link pending
cah-20231231_g6.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
cah-20231231_def.xml Edgar Link unprocessable
cah-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cah-20231231_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending